SOURCE: SkyePharma PLC

September 25, 2007 11:28 ET

SkyePharma PLC announces Sachs Biotech Conference

London, UK--(Marketwire - September 25, 2007) -


                SKYEPHARMA TO PRESENT AT SACHS ASSOCIATES

                7TH ANNUAL BIOTECH INVESTOR IN EUROPE CONFERENCE



LONDON, UK, 25 September 2007-- SkyePharma PLC (LSE: SKP) announces today that
the Company's Chief Operating Officer, Dr Ken Cunningham, will make a
presentation at the Sachs Associates 7th Annual Biotech Investor in Europe
Conference in  Zurich.  Dr Cunningham will deliver his presentation on Tuesday 2
October 2007 at 3.35 p.m. CEST (2.35 p.m. UK). Investors may access the slide
presentation at www.skyepharma.com under the Investor Relations tab.





For further information please contact:
SkyePharma PLC                    Frank Condella        +44 20 7491 1777
                                  Ken Cunningham
                                  Peter Grant

Financial Dynamics (UK Enquiries) David Yates           +44 20 7831 3113
                                  Deborah Scott

Trout Group (US Enquiries)        Christine Labaree      +1 617 583 1308
                                  Seth Lewis



About SkyePharma PLC

Using its proprietary drug delivery technologies, SkyePharma develops new
formulations of known molecules to provide a clinical advantage and life-cycle
extension. The Company has eleven approved products in the areas of oral,
inhalation and topical delivery that are marketed throughout the world by
leading pharmaceutical companies.

For more information, visit www.skyepharma.com




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END